earnings
OS
NYSE · OSTX
OS Therapies Incorporated
Healthcare · Biotechnology
$1.65
Down-$0.02 (-0.91%)
Updated Sep 29, 2026, 1:35 PM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 71.66M
- P/E ratio
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- $1.15 – $2.25
- Volume
- 353.42K
- Avg. volume
- 342.06K
Price performance · OSTX
OSTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 28, 2026
OSTX closed at $1.65 after 20 trading sessions, down 2.37% for the selected period.
- Last close
- $1.65
- Period change
- -2.37%
- Period low
- $1.65
- Period high
- $1.88
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | $1.66 | $1.6792 | $1.61 | $1.65 | 353.42K |
| Sep 25, 2026 | $1.67 | $1.68 | $1.64 | $1.66 | 171.42K |
| Sep 24, 2026 | $1.66 | $1.67 | $1.615 | $1.66 | 347.76K |
| Sep 23, 2026 | $1.76 | $1.77 | $1.64 | $1.65 | 654.5K |
| Sep 22, 2026 | $1.76 | $1.84 | $1.74 | $1.77 | 600.39K |
| Sep 21, 2026 | $1.81 | $1.815 | $1.74 | $1.74 | 637.06K |
| Sep 18, 2026 | $1.81 | $1.83 | $1.76 | $1.77 | 908.58K |
| Sep 17, 2026 | $1.80 | $2.00 | $1.80 | $1.83 | 2.23M |
| Sep 16, 2026 | $1.79 | $1.82 | $1.74 | $1.75 | 421.33K |
| Sep 15, 2026 | $1.78 | $1.81 | $1.71 | $1.78 | 1.05M |
| Sep 14, 2026 | $1.65 | $1.79 | $1.62 | $1.70 | 993.72K |
| Sep 11, 2026 | $1.81 | $1.8399 | $1.66 | $1.68 | 825.87K |
| Sep 10, 2026 | $1.87 | $1.92 | $1.81 | $1.82 | 547.91K |
| Sep 9, 2026 | $1.83 | $1.92 | $1.80 | $1.86 | 393.18K |
| Sep 8, 2026 | $1.96 | $2.015 | $1.7504 | $1.83 | 1.77M |
| Sep 4, 2026 | $1.84 | $1.96 | $1.84 | $1.88 | 982.58K |
| Sep 3, 2026 | $1.72 | $1.84 | $1.72 | $1.82 | 894.28K |
| Sep 2, 2026 | $1.68 | $1.72 | $1.61 | $1.71 | 530.47K |
| Sep 1, 2026 | $1.68 | $1.705 | $1.63 | $1.66 | 400.62K |
| Aug 31, 2026 | $1.62 | $1.6901 | $1.62 | $1.69 | 234.96K |
Latest OSTX news
The latest Smart Investors Daily articles mentioning OSTX.
Stock researchCompany · Financials
Loading stock research…